tiprankstipranks
Trending News
More News >
New Century Healthcare Holding Co. Ltd. (HK:1518)
:1518
Hong Kong Market

New Century Healthcare Holding Co. Ltd. (1518) AI Stock Analysis

Compare
0 Followers

Top Page

HK

New Century Healthcare Holding Co. Ltd.

(1518)

Rating:59Neutral
Price Target:
HK$1.00
▲(20.48%Upside)
The overall score is primarily impacted by declining financial performance and bearish technical indicators. Despite a favorable valuation, liquidity and momentum concerns weigh heavily on the stock's outlook.

New Century Healthcare Holding Co. Ltd. (1518) vs. iShares MSCI Hong Kong ETF (EWH)

New Century Healthcare Holding Co. Ltd. Business Overview & Revenue Model

Company DescriptionNew Century Healthcare Holding Co. Limited, an investment holding company, provides healthcare services to women and children in the People's Republic of China. The company offers paediatric, obstetric, and gynaecologic specialty services, as well as hospital consulting services. It also provides online healthcare services, as well as operates cafeteria and gift shop at its medical institutions. The company was founded in 2002 and is headquartered in Beijing, the People's Republic of China.
How the Company Makes MoneyNew Century Healthcare Holding Co. Ltd. generates revenue through its network of hospitals and clinics by providing a variety of healthcare services. The company earns income from outpatient and inpatient services, which include consultations, medical treatments, and surgeries for pediatric and obstetric care. Additionally, the company offers health management services, further contributing to its revenue streams. The company may also generate revenue through strategic partnerships with medical suppliers and insurance companies, enhancing its service offerings and patient reach. Key factors contributing to its earnings include the growing demand for specialized healthcare services in China, particularly in pediatric and maternal care, and the company's ability to maintain a strong reputation in delivering high-quality medical services.

New Century Healthcare Holding Co. Ltd. Financial Statement Overview

Summary
New Century Healthcare's financial performance is mixed. While the balance sheet shows stability with a favorable debt-to-equity ratio, declining revenue and profitability from the income statement, along with weakened cash flow, highlight challenges in operational efficiency and liquidity.
Income Statement
65
Positive
New Century Healthcare has shown a declining revenue trend, with a significant drop from 2023 to 2024. Gross profit margins have remained relatively stable, but net profit margins have decreased due to lower net income. EBIT and EBITDA margins also reflect a decrease, indicating a challenge in maintaining operational efficiency.
Balance Sheet
72
Positive
The company has a favorable debt-to-equity ratio, indicating moderate leverage, and shows a healthy equity ratio, suggesting stability in its capital structure. However, the return on equity has been negatively impacted by the reduction in net income, which is a concern for profitability.
Cash Flow
58
Neutral
Cash flow performance has weakened, with operating cash flow dropping significantly from 2023 to 2024. There is no available data for free cash flow growth or its ratio to net income, but the absence of positive cash flow trends is a risk factor for financial flexibility.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue846.50M933.07M636.46M632.57M512.78M
Gross Profit344.96M407.09M202.14M198.74M135.76M
EBITDA170.68M234.18M-209.54M41.78M-218.17M
Net Income47.38M84.16M-291.57M-85.26M-377.53M
Balance Sheet
Total Assets939.13M944.39M901.38M1.27B1.47B
Cash, Cash Equivalents and Short-Term Investments354.52M304.31M226.08M223.84M299.21M
Total Debt185.83M206.07M217.02M280.24M361.10M
Total Liabilities430.26M492.63M540.03M586.66M659.19M
Stockholders Equity553.83M522.28M438.26M737.46M838.63M
Cash Flow
Free Cash Flow114.10M148.21M66.16M9.10M-18.73M
Operating Cash Flow135.92M158.92M76.28M22.25M-4.22M
Investing Cash Flow-21.03M-8.64M-23.07M-15.74M47.82M
Financing Cash Flow-65.18M-73.07M-57.26M-79.84M-86.47M

New Century Healthcare Holding Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.83
Price Trends
50DMA
1.09
Negative
100DMA
1.11
Negative
200DMA
1.02
Negative
Market Momentum
MACD
-0.09
Positive
RSI
25.80
Positive
STOCH
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1518, the sentiment is Negative. The current price of 0.83 is below the 20-day moving average (MA) of 0.98, below the 50-day MA of 1.09, and below the 200-day MA of 1.02, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 25.80 is Positive, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1518.

New Century Healthcare Holding Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$384.46M8.945.95%11.67%0.81%27.55%
66
Neutral
HK$601.91M36.221.07%8.89%-1.20%-87.51%
64
Neutral
HK$450.00M20.555.02%11.11%-15.22%-21.37%
59
Neutral
HK$390.48M7.538.82%2.76%-10.82%-44.11%
58
Neutral
HK$315.03M15.012.73%3.46%-0.69%
51
Neutral
$7.55B0.30-61.90%2.27%17.11%1.58%
48
Neutral
HK$718.61M-10.78%-0.95%-128.35%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1518
New Century Healthcare Holding Co. Ltd.
0.85
0.02
2.41%
HK:1419
Human Health Holdings Ltd.
0.81
-0.22
-21.36%
HK:2189
Kato (Hong Kong) Holdings Ltd.
0.45
-0.06
-11.76%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.80
-0.53
-22.75%
HK:3869
Hospital Corporation of China Ltd
5.20
-1.20
-18.75%
HK:0722
UMP Healthcare Holdings Limited
0.46
0.03
6.98%

New Century Healthcare Holding Co. Ltd. Corporate Events

New Century Healthcare Announces Board Composition
Jun 30, 2025

New Century Healthcare Holding Co. Ltd. has announced the composition of its board of directors and their roles, effective June 30, 2025. The board includes executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, remuneration, and nomination committees. This announcement reflects the company’s commitment to structured governance and may influence its strategic decisions and stakeholder relations.

New Century Healthcare Updates Nomination Committee Terms
Jun 30, 2025

New Century Healthcare Holding Co. Ltd. has revised the terms of reference for its Nomination Committee, effective June 30, 2025. This update may impact the company’s governance structure and align its practices with the Listing Rules, potentially affecting its market positioning and stakeholder relations.

New Century Healthcare Announces Changes in Nomination Committee
Jun 30, 2025

New Century Healthcare Holding Co. Ltd. has announced a change in the composition of its Nomination Committee, effective June 30, 2025. Mr. Jiang Yanfu, an independent non-executive Director, has been re-designated as the chairman of the Nomination Committee, while Ms. Xin Hong, an executive Director, has been appointed as a new member. These changes align with upcoming amendments to the Listing Rules and Corporate Governance Code, aimed at enhancing the Board’s effectiveness and diversity, thereby improving corporate governance practices.

New Century Healthcare’s AGM Resolutions Passed Unanimously
May 22, 2025

New Century Healthcare Holding Co. Ltd. successfully held its Annual General Meeting on May 22, 2025, where all proposed resolutions were unanimously passed by shareholders. Key resolutions included the adoption of the company’s financial statements, re-election of directors, re-appointment of PricewaterhouseCoopers as auditors, and the declaration of a final dividend, reflecting strong shareholder support and stable governance.

New Century Healthcare Announces 2025 Annual General Meeting Agenda
Apr 28, 2025

New Century Healthcare Holding Co. Ltd. has announced its upcoming annual general meeting scheduled for May 22, 2025, in Beijing. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of auditors, and approval of a final dividend of HK$0.0221 per share. The meeting will also consider granting the board a mandate to issue additional shares, which could impact the company’s capital structure and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 01, 2025